IL-9 Induces Differentiation of TH17 Cells and Enhances Function of Foxp3؉ Natural Regulatory T Cells
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Regulatory T Cells Promote a Protective Th17-Associated Immune Response to Intestinal Bacterial Infection with C
ARTICLES nature publishing group Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium Z Wang1, C Friedrich1, SC Hagemann1, WH Korte1, N Goharani1, S Cording2, G Eberl2, T Sparwasser1,3 and M Lochner1,3 Intestinal infection with the mouse pathogen Citrobacter rodentium induces a strong local Th17 response in the colon. Although this inflammatory immune response helps to clear the pathogen, it also induces inflammation-associated pathology in the gut and thus, has to be tightly controlled. In this project, we therefore studied the impact of Foxp3 þ regulatory T cells (Treg) on the infectious and inflammatory processes elicited by the bacterial pathogen C. rodentium. Surprisingly, we found that depletion of Treg by diphtheria toxin in the Foxp3DTR (DEREG) mouse model resulted in impaired bacterial clearance in the colon, exacerbated body weight loss, and increased systemic dissemination of bacteria. Consistent with the enhanced susceptibility to infection, we found that the colonic Th17-associated T-cell response was impaired in Treg-depleted mice, suggesting that the presence of Treg is crucial for the establishment of a functional Th17 response after the infection in the gut. As a consequence of the impaired Th17 response, we also observed less inflammation-associated pathology in the colons of Treg-depleted mice. Interestingly, anti-interleukin (IL)-2 treatment of infected Treg-depleted mice restored Th17 induction, indicating that Treg support the induction of a protective -
Regulation of Type 17 Helper T-Cell Function by Nitric Oxide During Inflammation
Regulation of type 17 helper T-cell function by nitric oxide during inflammation Wanda Niedbalaa,1, Jose C. Alves-Filhoa,b,1, Sandra Y. Fukadaa,c,1, Silvio Manfredo Vieirab, Akio Mitania,d, Fabiane Sonegoa, Ananda Mirchandania, Daniele C. Nascimentoa, Fernando Q. Cunhab, and Foo Y. Liewa,2 aInstitute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow G12 8TA, Scotland; bDepartment of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo,14049-900, Ribeirão Preto, Brazil; cDepartment of Physics and Chemistry, Faculty of Pharmaceutical Sciences, University of São Paulo, 14040-903, Ribeirão Preto, Brazil; and dDepartment of Periodontology, School of Dentistry, Aichi Gakuin University, Nagoya, 464-8651 Japan Edited by Yoichiro Iwakura, Institute of Medical Science, University of Tokyo, Tokyo, Japan, and accepted by the Editorial Board April 19, 2011 (received for review January 13, 2011) − Type 17 helper T (Th17) cells are implicated in the pathogenesis suppressed the proliferation of freshly purified CD4+CD25 many of human autoimmune diseases. Development of Th17 can effector cells in vitro and ameliorated the effector T cell-mediated be enhanced by the activation of aryl hydrocarbon receptor (AHR) colitis and collagen-induced arthritis in the mouse in an IL-10– whose ligands include the environmental pollutant dioxin, poten- dependent manner. Both Th1 and Treg cells are pivotal to auto- tially linking environmental factors to the increased prevalence of immune diseases, indicating that NO may be a key player in mod- autoimmune disease. We report here that nitric oxide (NO) can ulating inflammatory disease. suppress the proliferation and function of polarized murine and Th17 cell differentiation is dependent on IL-6, IL-1, and TGF- β (with potential species-specific differences) and is enhanced human Th17 cells. -
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. -
Cytokine Nomenclature
RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B -
Transcriptional Control of Tissue-Resident Memory T Cell Generation
Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells. -
Type 2 Immunity in Tissue Repair and Fibrosis
REVIEWS Type 2 immunity in tissue repair and fibrosis Richard L. Gieseck III1, Mark S. Wilson2 and Thomas A. Wynn1 Abstract | Type 2 immunity is characterized by the production of IL‑4, IL‑5, IL‑9 and IL‑13, and this immune response is commonly observed in tissues during allergic inflammation or infection with helminth parasites. However, many of the key cell types associated with type 2 immune responses — including T helper 2 cells, eosinophils, mast cells, basophils, type 2 innate lymphoid cells and IL‑4- and IL‑13‑activated macrophages — also regulate tissue repair following injury. Indeed, these cell populations engage in crucial protective activity by reducing tissue inflammation and activating important tissue-regenerative mechanisms. Nevertheless, when type 2 cytokine-mediated repair processes become chronic, over-exuberant or dysregulated, they can also contribute to the development of pathological fibrosis in many different organ systems. In this Review, we discuss the mechanisms by which type 2 immunity contributes to tissue regeneration and fibrosis following injury. Type 2 immunity is characterized by increased pro‑ disorders remain unclear, although persistent activation duction of the cytokines IL‑4, IL‑5, IL‑9 and IL‑13 of tissue repair pathways is a major contributing mech‑ (REF. 1) . The T helper 1 (TH1) and TH2 paradigm was anism in most cases. In this Review, we provide a brief first described approximately three decades ago2, and overview of fibrotic diseases that have been linked to for many of the intervening years, type 2 immunity activation of type 2 immunity, discuss the various mech‑ was largely considered as a simple counter-regulatory anisms that contribute to the initiation and maintenance mechanism controlling type 1 immunity3 (BOX 1). -
Review Article Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2013, Article ID 968549, 13 pages http://dx.doi.org/10.1155/2013/968549 Review Article Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases Ning Qu,1 Mingli Xu,2 Izuru Mizoguchi,3 Jun-ichi Furusawa,3 Kotaro Kaneko,3 Kazunori Watanabe,3 Junichiro Mizuguchi,4 Masahiro Itoh,1 Yutaka Kawakami,2 and Takayuki Yoshimoto3 1 DepartmentofAnatomy,TokyoMedicalUniversity,6-1-1Shinjuku,Shinjuku-ku,Tokyo160-8402,Japan 2 Division of Cellular Signaling, Institute for Advanced Medical Research School of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan 3 Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo160-8402, Japan 4 Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan Correspondence should be addressed to Takayuki Yoshimoto; [email protected] Received 12 April 2013; Accepted 25 June 2013 Academic Editor: William O’Connor Jr. Copyright © 2013 Ning Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. T-helper 17 (Th17) cells are characterized by producing interleukin-17 (IL-17, also called IL-17A), IL-17F, IL-21, and IL-22 and potentially TNF- and IL-6 upon certain stimulation. IL-23, which promotes Th17 cell development, as well as IL-17 and IL-22 produced by the Th17 cells plays essential roles in various inflammatory diseases, such as experimental autoimmune encephalomyelitis, rheumatoid arthritis, colitis, and Concanavalin A-induced hepatitis. -
HP Turns 17: T Helper 17 Cell Response During Hypersensitivity
University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 5-2012 HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it Hossam Abdelsamed University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Immunology Commons, Medical Microbiology Commons, and the Medical Molecular Biology Commons Recommended Citation Abdelsamed, Hossam , "HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it" (2012). Theses and Dissertations (ETD). Paper 6. http://dx.doi.org/10.21007/etd.cghs.2012.0002. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. HP Turns 17: T helper 17 cell response during hypersensitivity pneumonitis (HP) and factors controlling it Document Type Dissertation Degree Name Doctor of Philosophy (Medical Science) Program Microbiology, Molecular Biology and Biochemistry Track Microbial Pathogenesis, Immunology, and Inflammation Research Advisor Elizabeth A. Fitzpatrick, Ph.D. Committee David D. Brand, Ph.D. Fabio C. Re, Ph.D. Susan E. Senogles, Ph.D. Christopher M. Waters, Ph.D. DOI 10.21007/etd.cghs.2012.0002 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/6 HP TURNS 17: T HELPER 17 CELL RESPONSE DURING HYPERSENSITIVITY PNEUMONITIS (HP) AND FACTORS CONTROLLING IT A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Hossam Abdelsamed May 2012 Portions of Chapter 3 © 2012 by BioMed Central Ltd. -
Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck. -
Genetic Controls of Th17 Cell Differentiation and Plasticity
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 43, No. 1, 1-6, January 2011 Genetic controls of Th17 cell differentiation and plasticity Chen Dong1 Th cell differentiation is instructed by distinct environmental cytokines, which signals through Department of Immunology and Center for Inflammation and Cancer STAT or other inducible but generally ubiquitous MD Anderson Cancer Center transcription factors. These factors then upregulate Houston, TX, USA the expression of lineage-specific transcription fa- 1Correspondence: Tel, 1-713-563-3203; ctors, which function not only to promote its own Fax, 1-713-563-0604; E-mail, [email protected] lineage differentiation but also to inhibit the al- DOI 10.3858/emm.2011.43.1.007 ternate differentiation pathways. There are exten- sive cross-regulations of lineage-determining trans- cription factors. Moreover, there is growing evi- Accepted 22 December 2010 Available Online 23 December 2010 dence that Th cell lineage commitment can be plastic in certain circumstances. Here, I summarize Abbreviation: Th cells, T helper cells our current understanding on the genetic controls of Th17 cell lineage differentiation and discuss on the evidence and mechanisms underlying their Abstract plasticity. CD4+ T lymphocytes play a major role in regulation of adaptive immunity. Upon activation, naïve T cells dif- Transcriptional control of Th17 cell ferentiate into different functional subsets. In addition differentiation to the classical Th1 and Th2 cells, several novel effector T cell subsets have been recently identified, including Th17 cell differentiation can be induced by the Th17 cells. There has been rapid progress in character- combination of TGFβ and IL-6 or IL-21 (Dong, izing the development and function of Th17 cells. -
Down Syndrome Acute Lymphoblastic Leukemia, a Highly Heterogeneous
Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010). Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115(5):1006-1017. University of Zurich Postprint available at: Zurich Open Repository and Archive http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Winterthurerstr. 190 Originally published at: CH-8057 Zurich Blood 2010, 115(5):1006-1017. http://www.zora.uzh.ch Year: 2010 Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010). -
Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements Michelle Lauren Robinette Washington University in St
Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2018 Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements Michelle Lauren Robinette Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, and the Medical Immunology Commons Recommended Citation Robinette, Michelle Lauren, "Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements" (2018). Arts & Sciences Electronic Theses and Dissertations. 1571. https://openscholarship.wustl.edu/art_sci_etds/1571 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Immunology Dissertation Examination Committee: Marco Colonna, Chair Maxim Artyomov Takeshi Egawa Gwen Randolph Wayne Yokoyama Innate Lymphoid Cells: Transcriptional Profiles and Cytokine Developmental Requirements by Michelle Lauren Robinette A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements